Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

China-Based Ivy Capital Invests in Betagenon's Clinical Stage AMPK Activator Program

prnasiaJanuary 20, 2020

Tag: Balticgruppen Bio , Ivy Capital , Clinical Stage AMPK Activator Program

PharmaSources Customer Service